Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Ya-wei Yuan"'
Autor:
An-An Xu, Jing-Jing Miao, Lin Wang, An-Chuan Li, Fei Han, Xun-Fan Shao, Zhi-Wen Mo, Shao-Min Huang, Ya-Wei Yuan, Xiao-Wu Deng, Chong Zhao
Publikováno v:
Radiation Oncology, Vol 18, Iss 1, Pp 1-10 (2023)
Abstract Background To analysis the clinical outcomes of concurrent chemoradiotherapy (CCRT) alone based on 10-year results for loco-regionally advanced nasopharyngeal carcinoma (LANPC), so as to provide evidence for individualized treatment strategy
Externí odkaz:
https://doaj.org/article/00ae3b7069b848db8cc1a06c3770661d
Autor:
Ying-Ying Liang, Fei-Yu Niu, An-An Xu, Li-Li Jiang, Chun-shan Liu, Hui-ping Liang, Yu-Fan Huang, Xun-Fan Shao, Zhi-Wen Mo, Ya-Wei Yuan
Publikováno v:
Cell Death and Disease, Vol 13, Iss 2, Pp 1-10 (2022)
Abstract Worldwide, nasopharyngeal carcinoma (NPC) is a rare head and neck cancer; however, it is a common malignancy in southern China. Radiotherapy is the most important treatment strategy for NPC. However, although radiotherapy is a strong tool to
Externí odkaz:
https://doaj.org/article/7dd2881a73dd4a4e87b343c6d37f8109
Autor:
Jian Zhang, Zi-Qi Zheng, Ya-Wei Yuan, Pan-Pan Zhang, Ying-Qin Li, Ya-Qin Wang, Xin-Ran Tang, Xin Wen, Xiao-Hong Hong, Yuan Lei, Qing-Mei He, Xiao-Jing Yang, Ying Sun, Jun Ma, Na Liu
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 23, Iss 11, Pp 1144-1146 (2021)
Externí odkaz:
https://doaj.org/article/42b3f12ae45046fbb33a551eac3cb519
Autor:
Ze-Jiang Zhan, Wen-Yu Yao, Fang Zhang, Wen-Ze Qiu, Kai- Liao, Jian-Hui Feng, Jin-Yun Tan, Hui Liu, Tai-Ze Yuan, Rong-Hui Zheng, Ya-Wei Yuan
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
BackgroundThe optimal second-line systemic treatment model for recurrent and/or metastatic head and neck squamous cell carcinoma (R/M HNSCC) remains controversial. A Bayesian network meta-analysis (NMA) was performed to address this issue with regard
Externí odkaz:
https://doaj.org/article/a7a9fb44ce8a4ac6aab708bf08210b98
Autor:
Jian Zhang, Zi-Qi Zheng, Ya-Wei Yuan, Pan-Pan Zhang, Ying-Qin Li, Ya-Qin Wang, Xin-Ran Tang, Xin Wen, Xiao-Hong Hong, Yuan Lei, Qing-Mei He, Xiao-Jing Yang, Ying Sun, Jun Ma, Na Liu
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 21, Iss 3, Pp 311-321 (2019)
DNA methylation is an important epigenetic change in carcinogenesis. However, the function and mechanism of DNA methylation dysregulation in nasopharyngeal carcinoma (NPC) is still largely unclear. Our previous genome-wide microarray data showed that
Externí odkaz:
https://doaj.org/article/9f970a384b7a408eba1eede882f62e07
Objective: This study aimed to explore the clinical value of adjuvant chemotherapy (ACT) in locoregionally advanced nasopharyngeal carcinoma (LANC) following concurrent chemoradiotherapy (CCRT) and induction chemotherapy (ICT).Methods: We included 83
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4ee1533530aac0ad9ade79fab99fcbb
https://doi.org/10.21203/rs.3.rs-848732/v1
https://doi.org/10.21203/rs.3.rs-848732/v1
Autor:
Ze-Jiang Zhan, Rui-Xin Zhang, Wen-Ze Qiu, Guo Li, Tai-Ze Yuan, Zhong-Yuan Liu, Kai Liao, Ya-Wei Yuan, Hao-Yun Tao, Rong-Hui Zheng
Publikováno v:
Journal of Cancer
Aims: This study aimed to investigate the clinical value of induction chemotherapy (IC) with docetaxel, 5-fluorouracil plus nedaplatin followed by concurrent chemoradiotherapy (CCRT) with nedaplatin for locoregional advanced nasopharyngeal carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49e7b99c29039f0637eae3b0a99f4766
https://doi.org/10.7150/jca.47090
https://doi.org/10.7150/jca.47090
Autor:
Xian-Tao Lin, Muy-Teck Teh, Yingying Liang, Li-Li Jiang, Xiaoting Huang, Xu-Bin Deng, Ya-Wei Yuan, Zhi-Wen Mo
Publikováno v:
Cell Death & Disease
Cell Death and Disease, Vol 11, Iss 10, Pp 1-12 (2020)
Cell Death and Disease, Vol 11, Iss 10, Pp 1-12 (2020)
Nasopharyngeal carcinoma (NPC) is a highly aggressive tumor characterized by distant metastasis. Deletion or down-regulation of the tumor suppressor protein ras-association domain family protein1 isoform A (RASSF1A) has been confirmed to be a key eve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b490372fa5d38fbe17b42256de90157
https://pubmed.ncbi.nlm.nih.gov/33057010
https://pubmed.ncbi.nlm.nih.gov/33057010
Autor:
Wang-Yu Cai, Ying Long, Yanjun Mi, Wei Zhang, Feng Ye, Mao-Li Chen, Yong Zeng, Qi-Cong Luo, Jia-Xing Zhao, Guo-Dong Ye, Dong-Yan Shen, Ya-Wei Yuan, Shu-Yu Yang, Chengfu Cai
Publikováno v:
Oncotarget
Marked up-regulation of aldose reductase (AR) is reportedly associated with the development of hepatocellular carcinoma (HCC). We investigated how aberrantly overexpressed AR might promote oncogenic transformation in liver cells and tissues. We found
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e1517b56c1a901ec269c1acea2b340a
https://doi.org/10.18632/oncotarget.17791
https://doi.org/10.18632/oncotarget.17791
Autor:
Zhi-Wen Mo, Ya-Wei Yuan, Xu-Bin Deng, Yingying Liang, Li-Si Zeng, Shao Xunfan, Xian-Tao Lin, Bin Wang
Publikováno v:
Cancer letters. 432
Ras association domain family member 6 (RASSF6) has been shown to act as a tumor suppressor and predictor of poor prognosis in renal cell carcinoma (RCC). However, little is known about the effects of RASSF6 on sorafenib resistance or the underlying
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc29c07216b95b2048f8cd22692ec1b1
https://pubmed.ncbi.nlm.nih.gov/29864454
https://pubmed.ncbi.nlm.nih.gov/29864454